Company / Book Value per Share
ArriVent BioPharma, Inc. Book Value per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$8.187
FY2024
5-year range
-$71.554 / $8.187
FY2023-FY2024
Trend
+111.4%
vs FY2023
Sector context
#70 of 209
Health Care
What the data says
At $8.187, ArriVent BioPharma, Inc.'s book value per share ranks #70 of 209 in the Health Care sector.
Based on SEC 10-K filings.
$8.187 in FY2024.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#70 of 209 in Health CareTop 33% of 209This company $8.187 Sector average $189.406
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2024, book value per share increased 111.4% year-over-year.
- Ranks #70 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $8.187 | +111.4% |
| FY2023 | -$71.554 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026